| pubmed-article:12735971 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12735971 | lifeskim:mentions | umls-concept:C0007114 | lld:lifeskim |
| pubmed-article:12735971 | lifeskim:mentions | umls-concept:C0030351 | lld:lifeskim |
| pubmed-article:12735971 | lifeskim:mentions | umls-concept:C1521827 | lld:lifeskim |
| pubmed-article:12735971 | lifeskim:mentions | umls-concept:C1522326 | lld:lifeskim |
| pubmed-article:12735971 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:12735971 | pubmed:dateCreated | 2003-5-8 | lld:pubmed |
| pubmed-article:12735971 | pubmed:abstractText | For homogeneous delivery of beta radiation to skin cancer, we developed a simple method for preparing (188) Re-labeled nitrocellulose paper. The homogeneity and stability of the labeled paper were investigated. Absorbed dose estimates were calculated using the Monte-Carlo method. A 74-MBq (188) Re-labeled paper with 1-cm diameter delivered 147.2 Gy up to 1-mm depth after 2-h irradiation. Animal experiments on tumor-bearing mice showed that 50 Gy is an adequate dose for treating skin cancer. Tumors disappeared 7 days after irradiation in all the groups irradiated by 50 or 100 Gy. The (188) Re-labeled paper provided a convenient, economical, effective, and non-invasive method of treating skin cancer. | lld:pubmed |
| pubmed-article:12735971 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12735971 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12735971 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12735971 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12735971 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12735971 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12735971 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12735971 | pubmed:month | May | lld:pubmed |
| pubmed-article:12735971 | pubmed:issn | 0969-8043 | lld:pubmed |
| pubmed-article:12735971 | pubmed:author | pubmed-author:ChangYoung... | lld:pubmed |
| pubmed-article:12735971 | pubmed:author | pubmed-author:JeongJae... | lld:pubmed |
| pubmed-article:12735971 | pubmed:author | pubmed-author:LeeMyung... | lld:pubmed |
| pubmed-article:12735971 | pubmed:author | pubmed-author:LeeDong SooDS | lld:pubmed |
| pubmed-article:12735971 | pubmed:author | pubmed-author:ChungJune-Key... | lld:pubmed |
| pubmed-article:12735971 | pubmed:author | pubmed-author:KimEun-HeeEH | lld:pubmed |
| pubmed-article:12735971 | pubmed:author | pubmed-author:LeeYong JinYJ | lld:pubmed |
| pubmed-article:12735971 | pubmed:author | pubmed-author:SonMiwonM | lld:pubmed |
| pubmed-article:12735971 | pubmed:author | pubmed-author:KimYoung... | lld:pubmed |
| pubmed-article:12735971 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12735971 | pubmed:volume | 58 | lld:pubmed |
| pubmed-article:12735971 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12735971 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12735971 | pubmed:pagination | 551-5 | lld:pubmed |
| pubmed-article:12735971 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12735971 | pubmed:meshHeading | pubmed-meshheading:12735971... | lld:pubmed |
| pubmed-article:12735971 | pubmed:meshHeading | pubmed-meshheading:12735971... | lld:pubmed |
| pubmed-article:12735971 | pubmed:meshHeading | pubmed-meshheading:12735971... | lld:pubmed |
| pubmed-article:12735971 | pubmed:meshHeading | pubmed-meshheading:12735971... | lld:pubmed |
| pubmed-article:12735971 | pubmed:meshHeading | pubmed-meshheading:12735971... | lld:pubmed |
| pubmed-article:12735971 | pubmed:meshHeading | pubmed-meshheading:12735971... | lld:pubmed |
| pubmed-article:12735971 | pubmed:meshHeading | pubmed-meshheading:12735971... | lld:pubmed |
| pubmed-article:12735971 | pubmed:meshHeading | pubmed-meshheading:12735971... | lld:pubmed |
| pubmed-article:12735971 | pubmed:meshHeading | pubmed-meshheading:12735971... | lld:pubmed |
| pubmed-article:12735971 | pubmed:meshHeading | pubmed-meshheading:12735971... | lld:pubmed |
| pubmed-article:12735971 | pubmed:meshHeading | pubmed-meshheading:12735971... | lld:pubmed |
| pubmed-article:12735971 | pubmed:meshHeading | pubmed-meshheading:12735971... | lld:pubmed |
| pubmed-article:12735971 | pubmed:meshHeading | pubmed-meshheading:12735971... | lld:pubmed |
| pubmed-article:12735971 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12735971 | pubmed:articleTitle | Preparation of (188) Re-labeled paper for treating skin cancer. | lld:pubmed |
| pubmed-article:12735971 | pubmed:affiliation | Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, South Korea. | lld:pubmed |
| pubmed-article:12735971 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12735971 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
